Exploiting natural product assembly line genomics and synthetic biology for discovery and optimisation of novel agrochemicals
Exploiting natural product assembly line genomics and synthetic biology for discovery and optimisation of novel agrochemicals
批准号:
BB/K002341/1
负责人:
Gregory Challis
金额:
$452.6万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Microorganisms including bacteria and fungi are everywhere in the environment. Although a few microorganisms have roles in causing disease, most microorganisms are harmless, and many of them actually produce medicines and chemicals useful to man. A good example is penicillin which is produced by a fungus and used as an effective antibiotic in human and animal medicine. Other compounds include anticancer drugs, drugs which allow organ transplants by suppressing the immune system and anticholesterol drugs. Many microbes also produce compounds of huge importance in agriculture which can be used as insecticides, herbicides and fungicides. It is estimated that around 40% of current world food productivity would be lost without these. As the world population grows and as climate change takes hold efficient food production and food security will become more important and the roles of these naturally occurring compounds will increase yet further. Penicillins came into use during the 1940s, and for around half a century research provided a steady stream of newly discovered natural products. However, traditional approaches began to fail as more and more compounds were discovered because the available methods kept finding the same known compounds. This led companies to try other avenues to provide new compounds for use as medicines and agrochemicals - however fully synthetic compounds have not proven as successful as natural products. Over the past decade academic research, much funded in the UK by BBSRC, but also an international effort, has led to the understanding that most microbes have the capacity to produce very many more compounds than observed - perhaps only 10% of a given organism's potential has been collected to-date. Genome sequencing has revealed that the biosynthetic potential of known organisms is huge - and new organisms are continually being found. If the 90% of unused genes in just the known organisms could be activated there could be a strong flow of new compounds for testing as medicines and agrochemicals - this flow could be increased to a flood if a generic technology could exploit all the as-yet undiscovered microbes. In parallel with the genome sequencing efforts huge progress has also been made in understanding the genes, enzymes and chemistry involved in the microbial synthesis of secondary metabolites. This now allows the pathways responsible for the synthesis of secondary metabolites in microbes to be engineered to produce yet more compounds. The confluence of cheap whole genome sequencing and the ability to engineer microbial pathways underpins this research proposal. The project will be a collaboration between 6 partners: the Challis group at Warwick, expert in microbial genome analysis; the Leadlay group at Cambridge, expert in bacterial polyketide biosynthesis; the Micklefield group in Manchester, expert in bacterial peptide production; the Cox group in Bristol expert in fungal biosynthesis; and Syngenta and Biotica, UK companies with major interest in secondary metabolites. We will obtain the genome sequences of bacteria and fungi known to produce agrochemically useful compounds. We will find the genes responsible for their production and recombine and engineer them to make higher amounts of these compounds, and then libraries of related compounds for testing. We will work with partners in the international agrochemical company Syngenta to develop these as new herbicides, insecticides and fungicides, while partners at the Biotechnology company Biotica will focus on compounds with use in human medicine. Overall we aim to develop a platform technology which can exploit the potential of microbes for the production of useful compounds for use in agriculture and medicine. We will also disseminate our results widely and undertake outreach activities to increase public awareness of industrial biotechnology and the role of genetic engineering and microbiology in ensuring future food security.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.simyco.2016.11.002
发表时间:
2016-09
期刊:
Studies in mycology
影响因子:
16.5
作者:
[de Mattos-Shipley KM, Ford KL, Alberti F, Banks AM, Bailey AM, Foster GD]
通讯作者:
Foster GD
DOI:
10.1039/c6sc02803a
发表时间:
2017-01-01
期刊:
Chemical science
影响因子:
8.4
作者:
[Awodi UR, Ronan JL, Masschelein J, de Los Santos ELC, Challis GL]
通讯作者:
Challis GL
DOI:
10.1038/s41589-022-01127-y
发表时间:
2022-12
期刊:
Nature chemical biology
影响因子:
14.8
作者:
[Hobson C, Jenner M, Jian X, Griffiths D, Roberts DM, Rey-Carrizo M, Challis GL]
通讯作者:
Challis GL
DOI:
10.3762/bjoc.13.238
发表时间:
2017
期刊:
Beilstein journal of organic chemistry
影响因子:
2.7
作者:
[Hong H, Samborskyy M, Usachova K, Schnatz K, Leadlay PF]
通讯作者:
Leadlay PF
DOI:
10.1039/d0sc04309e
发表时间:
2020-10-07
期刊:
Chemical science
影响因子:
8.4
作者:
[de Mattos-Shipley KMJ, Spencer CE, Greco C, Heard DM, O'Flynn DE, Dao TT, Song Z, Mulholland NP, Vincent JL, Simpson TJ, Cox RJ, Bailey AM, Willis CL]
通讯作者:
Willis CL
GEN2NCE - a synthetic biology platform for natural product discovery
-
批准号:BB/T017163/1
-
项目类别:Research Grant
-
资助金额:$25.29万
-
财政年份:2020
-
负责人:Gregory Challis
-
依托单位:
Gen2NCE - a genomics-driven platform for novel bioactive natural product discovery
-
批准号:BB/T010053/1
-
项目类别:Research Grant
-
资助金额:$1.37万
-
财政年份:2019
-
负责人:Gregory Challis
-
依托单位:
Establishing the Efficacy, Safety and Persistence of biopesticides based on naturally occurring beneficial bacteria
-
批准号:BB/S008020/1
-
项目类别:Research Grant
-
资助金额:$45.97万
-
财政年份:2019
-
负责人:Gregory Challis
-
依托单位:
EVOBIOTIC: Capturing the natural antibiotic'ome: Developing Nature's EVOlved AntiBIOTIC
-
批准号:MR/N501839/1
-
项目类别:Research Grant
-
资助金额:$34.89万
-
财政年份:2015
-
负责人:Gregory Challis
-
依托单位:
Exploitation of Burkholderia bacteria as novel antibiotic producers using a genome mining approach
-
批准号:BB/L023342/1
-
项目类别:Research Grant
-
资助金额:$45.2万
-
财政年份:2014
-
负责人:Gregory Challis
-
依托单位:
Exploiting microbial genomics and synthetic biology for discovery of novel antibiotics
-
批准号:BB/L010852/1
-
项目类别:Research Grant
-
资助金额:$3.24万
-
财政年份:2013
-
负责人:Gregory Challis
-
依托单位:
Elucidating and exploiting cytochrome P450 TxtE-catalysed tryptophan nitration in thaxtomin phytotoxin biosynthesis
-
批准号:BB/H006281/1
-
项目类别:Research Grant
-
资助金额:$42.15万
-
财政年份:2010
-
负责人:Gregory Challis
-
依托单位:
Elucidation and inhibition of the biosynthetic pathway to the anthrax stealth siderophore petrobactin
-
批准号:BB/F013760/1
-
项目类别:Research Grant
-
资助金额:$49.11万
-
财政年份:2008
-
负责人:Gregory Challis
-
依托单位:
Elucidation of the unusual methylenomycin biosynthetic pathway in Streptomyces coelicolor
-
批准号:BB/E008003/1
-
项目类别:Research Grant
-
资助金额:$40.63万
-
财政年份:2006
-
负责人:Gregory Challis
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Natural超对称中的希格斯物理与暗物质研究
-
批准号:11775039
-
项目类别:面上项目
-
资助金额:52.0万元
-
批准年份:2017
-
负责人:郑思波
-
依托单位:
Natural超对称在LHC上的现象学研究
-
批准号:11405015
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2014
-
负责人:郑思波
-
依托单位:
双硅化合物反应及天然产物合成应用研究
-
批准号:21172150
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:宋振雷
-
依托单位:
受体编辑在天然自身反应性B细胞发育耐受中的作用和机制研究
-
批准号:30901336
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2009
-
负责人:邢影
-
依托单位:
海洋天然产物Amphidinolide G和H全合成研究
-
批准号:20772148
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2007
-
负责人:赵刚
-
依托单位:
抗肾小球基底膜抗体的免疫学特性在疾病发生和发展中的作用
-
批准号:30700752
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2007
-
负责人:崔昭
-
依托单位: